XML 69 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Income Tax (Tables)
12 Months Ended
Dec. 31, 2022
Business Combination, Significant Transaction and Sale of Business [Abstract]  
Schedule of Consolidated Statements of Financial Position Presentation in consolidated statements of financial position:
   December 31, 
   2022   2021 
Deferred taxes assets  $42,027   $46,364 
Deferred tax liabilities   (59,465)   (78,135)
   $(17,438)  $(31,771)
Schedule of Composition Composition:
   December 31, 
   2022   2021 
Net operating losses carried forward  $10,296   $8,775 
Intangibles, fixed asset and right-of-use assets   (39,307)   (52,436)
Lease liability   (166)   484 
Differences in measurement basis (cash basis for tax purposes)   2,213    3,084 
Other   9,526    8,322 
   $(17,438)  $(31,771)
Schedule of Pre-Tax Income Pre-tax income:
  

Year ended December 31,

 
   2022   2021   2020 
             
Domestic (Israel)  $181,953   $137,213   $106,974 
Foreign   47,757    46,798    36,782 
                
Total  $256,710   $184,011   $143,756 
Schedule of income tax (tax benefit) Income tax (tax benefit) consist of the following:
  

Year ended December 31,

 
   2022   2021   2020 
             
Current taxes  $75,407   $52,956   $23,015 
Deferred taxes   (20,172)   (10,342)   8,254 
                
Total  $55,235   $42,614   $31,269 

 

Schedule of Consolidated Statements of Profit or Loss The following table presents reconciliation between the theoretical tax expense, assuming that all income was taxed at statutory tax rates, and the actual income tax expense, as recorded in the Group’s consolidated statements of profit or loss:
  

Year ended December 31,

 
   2022   2021   2020 
             
Income before income taxes, as per the statement of operations  $256,710   $184,011   $143,756 
                
Statutory tax rate in Israel   23%   23%   23%
                
Tax computed at the statutory tax rate   59,043    42,323    33,064 
                
Non-deductible expenses (non-taxable income) net and tax-deductible costs not included in the accounting costs   720    3,667    2,544 
Effect of different tax rates   (1,273)   852    (774)
Release of trapped earnings (see note 22(a)(2)   711    3,531      
Effect of “Approved, Beneficiary or Preferred Enterprise” status   (5,579)   (7,338)   (5,426)
Deferred taxes on current losses (utilization of carry forward losses) and temporary differences for which a valuation allowance was provided, net   448    (84)   1,877 
Undistributed earnings   (461)   
-
    
-
 
Taxes in respect of prior years   890    891    280 
Uncertain tax positions   3,065    401    285 
Other   (2,329)   (1,629)   (581)
                
Taxes on income  $55,235   $42,614   $31,269
Schedule of Total Unrecognized Tax Benefits A reconciliation of the beginning and ending amount of total unrecognized tax benefits in Formula’s subsidiaries is as follows:
Balance as of January 1, 2021    $ 9,091  
         
Decrease in tax positions     (1,457 )
Increase in tax positions     2,906  
         
Balance as of December 31, 2021    $ 10,540  
         
Decrease in tax positions     (1,042 )
Increase in tax positions     4,455  
Statue limitation     (1,012 )
Balance as of December 31, 2022    $ 12,941